CAMPO, Gianluca Calogero
 Distribuzione geografica
Continente #
NA - Nord America 13763
EU - Europa 2830
AS - Asia 1662
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 3
Totale 18278
Nazione #
US - Stati Uniti d'America 13754
CN - Cina 1081
IT - Italia 618
UA - Ucraina 611
TR - Turchia 475
DE - Germania 400
PL - Polonia 288
GB - Regno Unito 278
SE - Svezia 276
FI - Finlandia 126
FR - Francia 118
BE - Belgio 66
VN - Vietnam 40
IN - India 21
IR - Iran 11
DK - Danimarca 10
RU - Federazione Russa 9
KR - Corea 8
CA - Canada 7
ES - Italia 6
JP - Giappone 6
RO - Romania 6
CO - Colombia 4
EU - Europa 4
HK - Hong Kong 4
PK - Pakistan 4
TW - Taiwan 4
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
NL - Olanda 3
AU - Australia 2
IE - Irlanda 2
MX - Messico 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
PH - Filippine 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 18278
Città #
Fairfield 2306
Woodbridge 1817
Houston 1174
Chandler 1034
Seattle 941
Ashburn 913
Wilmington 851
Ann Arbor 809
Cambridge 767
Jacksonville 758
Izmir 339
Princeton 325
Beijing 324
Warsaw 285
Nanjing 267
San Diego 206
Ferrara 177
Milan 143
Boardman 112
Bremen 80
Shenyang 74
Nanchang 72
Brussels 64
Redwood City 64
Falls Church 63
Jiaxing 50
Tianjin 50
Mountain View 44
Hebei 40
Dong Ket 39
Changsha 38
Addison 34
San Mateo 34
London 33
Norwalk 32
Jinan 26
Des Moines 23
Kunming 23
Bologna 22
Chicago 22
Orange 22
Augusta 21
Redmond 20
Ningbo 19
Auburn Hills 15
Dearborn 15
Zhengzhou 15
Shanghai 13
Taizhou 13
Leawood 12
Monmouth Junction 12
Napoli 12
Indiana 10
Guangzhou 9
Helsinki 9
Los Angeles 9
Hangzhou 8
Lanzhou 8
Lugo 8
Ardabil 7
Odense 6
Phoenix 6
Rovigo 6
Changchun 5
Haikou 5
Imola 5
Philadelphia 5
San Francisco 5
Vicenza 5
Ferrara di Monte Baldo 4
Mumbai 4
Paris 4
Poggio Renatico 4
Rovereto 4
Somma Vesuviana 4
Taipei 4
Ariano nel Polesine 3
Bondeno 3
Bozzolo 3
Brogliano 3
Camerino 3
Detroit 3
Duncan 3
Fuzhou 3
Jonzieux 3
Medicina 3
New Delhi 3
New Haven 3
New York 3
Palermo 3
Sheffield 3
Tokyo 3
Arezzo 2
Ashford 2
Bangalore 2
Bergamo 2
Boston 2
Chengdu 2
Civitanova Marche 2
Columbus 2
Totale 14872
Nome #
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 229
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 165
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 146
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 140
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 133
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 131
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 129
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 129
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 128
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 128
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 126
Fractional flow reserve: Current applications and overview of the available data 125
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 125
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 125
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 124
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention 123
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 122
Notch Signaling Regulates Immune Responses in Atherosclerosis 122
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 120
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 120
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 119
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 118
Reperfusion damage — a story of success, failure, and hope — 117
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 116
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 116
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 116
Poor response to clopidogrel: current and future options for its management 116
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 115
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 114
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 114
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 114
Can we improve myocardial protection during ischaemic injury? 114
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 111
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 111
The in vitro effects of verbascoside on human platelet aggregation 110
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 109
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 108
Mechanistic role of mPTP in ischemia-reperfusion injury 107
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 106
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 106
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 106
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 105
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 105
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 104
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 104
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 104
Characterization of Dermal Stem Cells of Diabetic Patients 104
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 104
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 103
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 103
A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. 102
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 102
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 101
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 101
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 101
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 100
Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche Emilia-Romagna registry) 100
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 100
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 99
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 99
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 97
Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions 97
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 97
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 97
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry 97
Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes 96
Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry 96
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 95
Fractional flow reserve implementation in daily clinical practice: A European survey 95
The Mitochondrial Permeability Transition Pore 95
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study 94
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 94
null 94
A Prospective Evaluation of a Standardized Strategy for the Use of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in ST-Segment Elevation Myocardial Infarction: Rationale and Design of the BVS STEMI STRATEGY-IT Study 94
Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis 94
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 93
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 93
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 93
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 93
Incidence and outcome of high on-treatment platelet reactivity in patients with non-st elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the VIP [verifynow and inhibition of platelet reactivity] study) 93
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 92
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study 92
New and old strategies to afford the liberal use of drug-eluting stents in real-life scenarios 92
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 92
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 92
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. 91
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 91
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 91
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 91
Tissue factor and coagulation factor VII levels during AMI: association with genotype and adverse events 90
Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results 90
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 90
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 90
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 89
Impact of culprit plaque and atherothrombotic components on incomplete stent apposition in patients with ST-elevation myocardial infarction treated with Everolimus-eluting stents-an OCTAVIA Substudy 88
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 88
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 88
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 86
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 86
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 85
Totale 10685
Categoria #
all - tutte 44802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 407
Totale 45209

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201899 0000 00 00 36331416
2018/20192652 7161426 1456 25623 218449610963
2019/20204794 661215187666 342553 473474 433435225130
2020/20213841 198262194489 231300 166498 174541536252
2021/20223161 274287207148 146163 193195 142239337830
2022/20232435 340126141235 406396 188268 335000
Totale 18933